Dana Farber Cancer Institute-Hematology/Oncology — Boston, Massachusetts

Dana Farber Cancer Institute-Hematology/Oncology is a clinical research site located in Boston, Massachusetts, United States 461099.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institute-Hematology/Oncology has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Limited-stage Small Cell Lung Cancer (LS-SCLC).

Sponsors: Shanghai Junshi Bioscience Co., Ltd..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institute-Hematology/Oncology?

Dana Farber Cancer Institute-Hematology/Oncology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institute-Hematology/Oncology conducted?

Dana Farber Cancer Institute-Hematology/Oncology has 1 clinical trials on record, with 1 currently active. Their work covers Limited-stage Small Cell Lung Cancer (LS-SCLC).

Is Dana Farber Cancer Institute-Hematology/Oncology accredited by Crixeo Health?

Dana Farber Cancer Institute-Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institute-Hematology/Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.